Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma-two case report studies

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 10, 2010, Pages 747-753

  Tanriver, Y ^a,e   Betz, M J ^c   Nibbe, L ^a   Pfluger, T ^d   Beuschlein, F ^c   Strowski, M Z ^b  

^a Department of Nephrology and Medical Intensive Care ^*  (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Medizinische Klinik Innenstadt   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

adrenal gland; cardiomyopathy; catecholamine induced cardiomyopathy; fever of unknown origin; pheochromocytoma; urosepsis

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CATECHOLAMINE; DOXAZOSIN; ENALAPRIL; IODINE 123; METIROSINE; METOPROLOL; MIBG IODINE 123; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENOXYBENZAMINE; PIPERACILLIN; PROPRANOLOL; RAMIPRIL; SIMVASTATIN; SULBACTAM; UNCLASSIFIED DRUG; VERAPAMIL;

ADD ON THERAPY; ADRENALECTOMY; ADULT; AGED; ANGINA PECTORIS; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CATECHOLAMINE EXCRETION; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; EPIGASTRIC PAIN; ESCHERICHIA COLI; FEMALE; FEVER; FOLLOW UP; HEART CONTRACTION; HISTOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; LOW DRUG DOSE; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TAKOTSUBO CARDIOMYOPATHY; THORAX PAIN; TREATMENT WITHDRAWAL; TUMOR VOLUME; UROSEPSIS; VOMITING;

ADRENAL GLAND NEOPLASMS; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; HYPERTENSION; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHEOCHROMOCYTOMA; SEPSIS; STRESS, PHYSIOLOGICAL; TAKOTSUBO CARDIOMYOPATHY;

EID: 78349281204     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1253413     Document Type: Article

References (38)

1. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992 147 1-10
2. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001 134 315-329
3. McNeil AR, Blok BH, Koelmeyer TD, et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 2000 30 648-652
4. Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004 11 423-436
5. Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004 27 193-202
6. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994 12 609-615
7. Sinclair AM, Isles CG, Brown I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987 147 1289-1293
8. Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet 2005 366 665-675
9. Neumann HP, Berger DP, Sigmund G, et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1993 329 1531-1538
10. Adler JT, Meyer-Rochow GY, Chen H, et al. Pheochromocytoma: current approaches and future directions. Oncologist 2008 13 779-793
11. Brouwers FM, Lenders JW, Eisenhofer G, et al. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003 4 121-128
12. Ueda T, Oka N, Matsumoto A, et al. Pheochromocytoma presenting as recurrent hypotension and syncope. Intern Med 2005 44 222-227
13. La Batide-Alanore A, Chatellier G, Plouin PF. Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertens 2003 21 1703-1707
14. Mannelli M, Ianni L, Cilotti A, et al. Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 1999 141 619-624
15. Newell KA, Prinz RA, Pickleman J, et al. Pheochromocytoma multisystem crisis. A surgical emergency. Arch Surg 1988 123 956-959
16. Boulkina LS, Newton CA, Drake AJ III, et al. Acute myocardial infarction attributable to adrenergic crises in a patient with pheochromocytoma and neurofibromatosis 1. Endocr Pract 2007 13 269-273
17. Salahuddin A, Rohr-Kirchgraber T, Shekar R, et al. Interleukin-6 in the fever and multiorgan crisis of pheochromocytoma. Scand J Infect Dis 1997 29 640-642
18. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998 19 101-143
19. Tischler AS, Perlman RL, Morse GM, et al. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J Neurochem 1983 40 364-370
20. Hoen S, Mazoit JX, Asehnoune K, et al. Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005 33 2737-2743
21. Mayfield KP, Soszynski D, Kozak W, et al. Beta-adrenergic receptor subtype effects on stress fever and thermoregulation. Neuroimmunomodulation 1999 6 305-317
22. Blaak EE, van Baak MA, Kempen KP, et al. Role of alpha- and beta-adrenoceptors in sympathetically mediated thermogenesis. Am J Physiol 1993 264 E11-E17
23. Schiffelers SL, Blaak EE, Saris WH, et al. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use. Clin Pharmacol Ther 2000 67 558-566
24. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007 3 92-102
25. Soares-Filho GL, Felix RC, Azevedo JC, et al. Broken Heart or Takotsubo Syndrome: Support for the neurohumoral hypothesis of stress cardiomyopathy. Prog Neuropsychopharmacol Biol Psychiatry 2009
26. Donohue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev 2005 10 311-316
27. Takizawa M, Kobayakawa N, Uozumi H, et al. A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy. Int J Cardiol 2007 114 e15-e17
28. Verrijcken A, Sciot R, Dubois CL. From trivial headache to life-threatening disease. Int J Cardiol 2009
29. Turley A, Graham R, Hall J. Takotsubo cardiomyopathy in two female patients: two case reports. Cases J 2008 1 325
30. Kalra PA, Thornton-Chan EW, Weinkove C, et al. Phaeochromocytoma presenting with acute intestinal ischaemia and shock. Postgrad Med J 1990 66 982
31. Maguire BM, Edwards ML, Breheny FX. Ischaemic enterocolitis: an unusual presentation of phaeochromocytoma. Med J Aust 1991 154 567-568
32. Salehi A, Legome EL, Eichhorn K, et al. Pheochromocytoma and bowel ischemia. J Emerg Med 1997 15 35-38
33. Karri V, Khan SL, Wilson Y. Bowel perforation as a presenting feature of pheochromocytoma: case report and literature review. Endocr Pract 2005 11 385-388
34. Karagiannis A, Mikhailidis DP, Athyros VG, et al. Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 2007 14 935-956
35. Jimenez C, Cote G, Arnold A, et al. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 2006 91 2851-2858
36. Proye C, Thevenin D, Cecat P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989 106 1149-1154
37. Walther MM. New therapeutic and surgical approaches for sporadic and hereditary pheochromocytoma. Ann N Y Acad Sci 2002 970 41-53
38. Steinsapir J, Carr AA, Prisant LM, et al. Metyrosine and pheochromocytoma. Arch Intern Med 1997 157 901-906